Nursing facility
Alpha Medical Laboratory LLC
Alpha Medical Laboratory LLC was paid $1.23M by Medicaid between Nov 2020 and Dec 2024, across 74 billing codes. Its largest line is 80050, General health panel — 11% of everything it billed.
33Billing provider infoALPHA MEDICAL LABORATORY LLC
TULSA, OK 74137
TULSA, OK 74137
33aNPI1154783074assigned 03/22/2016
33bProvider typeSkilled Nursing Facility
28Total paid$1.23M
24GClaims199,802
24DCodes billed74
24AFirst – last monthNov 2020 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 374 | $0.00 | |
| 2021 | 46,978 | $177K | |
| 2022 | 45,029 | $310K | |
| 2023 | 43,384 | $348K | |
| 2024incomplete | 64,037 | $396K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80050 | General health panel | 11% | 4,083 | 3,985 | $131K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 31,693 | 22,563 | $128K |
| 80053 | Comprehensive metabolic panel | 8.4% | 20,892 | 17,036 | $104K |
| 87187 | 6.5% | 3,813 | 3,298 | $80K | |
| 80061 | Lipid panel | 6.3% | 10,518 | 9,557 | $77K |
| 83036 | Hemoglobin; glycosylated (A1C) | 5.8% | 13,142 | 11,739 | $71K |
| 87481 | 5.7% | 3,796 | 3,201 | $70K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 4.7% | 2,080 | 1,611 | $58K |
| 87186 | 4.0% | 4,092 | 3,513 | $49K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.4% | 4,964 | 4,100 | $41K |
| 80164 | 3.2% | 5,010 | 4,384 | $40K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.7% | 6,823 | 5,781 | $34K |
62 more codes
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.7% | 872 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 7,904 | $30K |
| 80177 | 2.3% | 3,255 | $29K | |
| 83880 | 2.3% | 1,125 | $28K | |
| 84134 | 1.9% | 2,188 | $23K | |
| 87150 | 1.8% | 1,210 | $23K | |
| 87653 | 1.8% | 2,459 | $23K | |
| 87640 | 1.3% | 1,579 | $16K | |
| 82140 | <1% | 1,162 | $11K | |
| 90677 | <1% | 42 | $11K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 384 | $11K |
| 84439 | <1% | 1,532 | $10K | |
| 91322 | <1% | 63 | $9K | |
| 81001 | <1% | 5,699 | $9K | |
| 84153 | <1% | 755 | $8K | |
| 85610 | <1% | 2,565 | $8K | |
| 83735 | <1% | 2,545 | $7K | |
| 82607 | <1% | 1,560 | $7K | |
| 90480 | <1% | 132 | $5K | |
| 80178 | <1% | 808 | $4K | |
| 82977 | <1% | 894 | $3K | |
| 82728 | <1% | 427 | $3K | |
| 80185 | <1% | 422 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 391 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 98 | $3K |
| 82150 | <1% | 761 | $3K | |
| 83540 | <1% | 644 | $2K | |
| 87529 | <1% | 90 | $2K | |
| 87070 | <1% | 250 | $2K | |
| 90674 | <1% | 50 | $2K | |
| 82248 | <1% | 553 | $2K | |
| 82746 | <1% | 332 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 34 | $1K |
| 84100 | <1% | 1,009 | $1K | |
| 85652 | <1% | 627 | $1K | |
| 90682 | <1% | 20 | $1K | |
| 84466 | <1% | 138 | $1K | |
| 80076 | <1% | 298 | $1K | |
| 84436 | <1% | 282 | $990.97 | |
| 80175 | <1% | 84 | $781.38 | |
| 87088 | <1% | 222 | $714.51 | |
| 80156 | <1% | 80 | $502.06 | |
| 80159 | <1% | 41 | $460.03 | |
| G0008 | Administration of influenza virus vaccine | <1% | 167 | $408.36 |
| 84550 | <1% | 152 | $381.97 | |
| 86141 | <1% | 75 | $348.38 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 241 | $232.01 |
| 85379 | <1% | 38 | $188.39 | |
| 84152 | <1% | 28 | $150.70 | |
| 82550 | <1% | 58 | $147.78 | |
| 84479 | <1% | 88 | $112.53 | |
| 83550 | <1% | 27 | $101.01 | |
| 84132 | <1% | 35 | $95.71 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 35 | $86.10 |
| 84481 | <1% | 16 | $77.22 | |
| 83690 | <1% | 46 | $65.10 | |
| 80162 | <1% | 12 | $59.05 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 17,251 | $22.44 |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 20,419 | $11.03 |
| 80069 | <1% | 20 | $7.30 | |
| 87634 | 0% | 19 | $0.00 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 4,583 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGATES, ROBERT (MANAGING MEMBER)
| Provider | Location | Paid |
|---|---|---|
| Caldwell Toxicology Labs LLC | Tulsa, OK | $419K |
| Eyesight Healthcare, PLLC | Corpus Christi, TX | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.